Obvious benefits with the clinic model. Now the cost is the downside.
We all agree control of supply, education and so on are great advantages.
There are many models that can become viable for a bit of time until the market matures.
Ann: Clinic Rollout Update, page-18
Add EPN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EPN (ASX) Chart |
Day chart unavailable